Stereotaxis Acquires Access Point Technologies (APT)
May 13, 2024
Stereotaxis (NYSE: STXS) entered into a definitive share purchase agreement to acquire Access Point Technologies (APT), a Minnesota-based developer and manufacturer of electrophysiology (EP) diagnostic catheters. The deal consideration is payable in Stereotaxis common stock (upfront plus contingent milestone payments); Stereotaxis said APT is expected to contribute roughly $5 million of revenue in the first year and the acquisition is intended to add catheter development and manufacturing capabilities to accelerate EP and robotic endovascular offerings.
- Buyers
- Stereotaxis, Inc.
- Targets
- Access Point Technologies (APT)
- Sellers
- APT Holding Company, Inc.
- Industry
- Medical Devices
- Location
- Minnesota, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
HealthpointCapital Acquires Majority Stake in SteriCUBE Holdings, Inc.
April 10, 2024
Medical Devices
HealthpointCapital acquired a majority stake in SteriCUBE Holdings, Inc., the developer of the patented Multiple Tray Sterilization (MTS) System that eliminates disposable "blue wrap" used in surgical instrument tray sterilization. The investment will bring new leadership to SteriCUBE and aims to accelerate commercialization of the FDA-cleared system across hospitals and ambulatory surgical centers, driving cost, workflow and environmental benefits.
-
BiomX Acquires Adaptive Phage Therapeutics
March 18, 2024
Biotechnology
BiomX Inc. completed a stock-for-stock acquisition of Adaptive Phage Therapeutics (APT), making APT a wholly owned subsidiary and combining phage therapy capabilities and pipelines. Concurrently, BiomX raised $50 million in a private placement led by affiliates of Deerfield Management and the AMR Action Fund to advance two Phase 2 assets (BX004 and BX211) toward pivotal readouts in 2025–2026.
-
Catalyst Clinical Research Acquires Aptus Clinical
May 4, 2022
Healthcare Services
Catalyst Clinical Research, a portfolio company of NovaQuest Capital Management, has acquired U.K.-based Aptus Clinical to accelerate Catalyst's European expansion and broaden its oncology and early-phase clinical services. The deal creates a multi-region CRO operating across North America and Europe, increases Catalyst's patient reach by nearly 600 and lifts combined headcount to more than 800.
-
Boston Scientific Acquires Axonics, Inc.
November 15, 2024
Medical Devices
Boston Scientific Corporation agreed to and completed the acquisition of Axonics, Inc., a publicly traded medical technology company focused on sacral neuromodulation and urology devices, for $71 per share (approximately $3.7 billion equity value). The deal expands Boston Scientific’s urology portfolio by adding Axonics’ SNM therapy products and related technologies, expected to be accretive to its Urology business over time.
-
Transcat Acquires SteriQual, Inc.
July 12, 2023
Professional Services
Transcat, Inc. (Nasdaq: TRNS) acquired all of the capital stock of SteriQual, Inc., effective July 12, 2023, for $4.25 million paid in Transcat stock. The acquisition is a bolt-on to Transcat's Nexa Enterprise Asset Management business to expand its professional services and CQV (commissioning, qualification, validation) capabilities for life sciences customers.
-
Align Capital Partners Acquires StenTech
June 1, 2022
Manufacturing
Align Capital Partners completed an acquisition of StenTech, a North American manufacturer of SMT stencils, pallets, tooling and related components. ACP's investment is the company's first institutional capital and will support commercial and operational expansion while founder Sibthain "Sip" Akbar transitions to the board and Brent Nolan becomes President.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.